Advertisement

Whole-Lung Lavage

Chapter

Abstract

Pulmonary alveolar proteinosis (PAP) is a disease characterized by the accumulation of amorphous lipoproteinaceous material in the alveoli. Whole-lung lavage (WLL) is the first line of treatment for patients symptomatic from PAP. The procedure involves intubating the patient with a double-lumen endotracheal tube to isolate the two lungs, ventilating one lung while performing a large-volume lavage (up to 20 L) of the other lung with warmed normal saline. Aliquots of 1 L on saline are instilled into the lung, chest percussion is performed, and the proteinaceous effluent is drained by gravity. The procedure is repeated for the contralateral lung. The process physically removes the amorphous material from the alveoli and improves oxygenation. Intraoperative refractory hypoxia is the most common complication of the procedure but tends to be self-limited and transient. If required by the severity of hypoxia, extracorporeal membrane oxygenation (ECMO) may be utilized to complete the procedure. There is a significant improvement, both clinically and radiologically, following the procedure. Some patients may require the procedure repeatedly during the course of the disease.

Keywords

Extracorporeal Membrane Oxygenation Pulmonary Alveolar Proteinosis Contralateral Lung Proteinaceous Material Pulmonary Alveolar Proteinosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Suggested Reading

  1. 1.
    Michaud G, Reddy C, Ernst A. Whole lung lavage for pulmonary alveolar proteinosis. Chest. 2009;136:1678–81.PubMedCrossRefGoogle Scholar
  2. 2.
    Ramirez JR, Kieffer RF, Ball WC. Bronchopulmonary lavage in man. Ann Intern Med. 1965;63:819–28.PubMedCrossRefGoogle Scholar
  3. 3.
    Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis progress in the first 44 years. Am J Respir Crit Care Med. 2002;166:215–35.PubMedCrossRefGoogle Scholar
  4. 4.
    Beccaria M, Luisetti M, Rodi G, et al. Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. Eur Respir J. 2004;23:526.PubMedCrossRefGoogle Scholar
  5. 5.
    Hammon WE, McCaffree DR, Cucchiara AJ. A comparison of manual to mechanical chest percussion for clearance of alveolar material in patients with pulmonary alveolar proteinosis (phospholipidosis). Chest. 1993;103:1409.PubMedCrossRefGoogle Scholar
  6. 6.
    Ramirez J. Pulmonary alveolar proteinosis: treatment by massive bronchopulmonary lavage. Arch Intern Med. 1967;119:147–56.PubMedCrossRefGoogle Scholar
  7. 7.
    Rogers RM, Levin DC, Gray BA, et al. Physiologic effects of bronchopulmonary lavage in alveolar proteinosis. Am Rev Respir Dis. 1978;118:255–64.PubMedGoogle Scholar
  8. 8.
    Rogers RM, Szidon JP, Shelburne J, et al. Hemodynamic response of the pulmonary circulation to bronchopulmonary lavage in man. N Engl J Med. 1972;286:1230–3.PubMedCrossRefGoogle Scholar
  9. 9.
    Ben-Abraham R, Greenfeld A, Rozenman J, et al. Pulmonary alveolar proteinosis: step-by-step perioperative care of whole lung lavage procedure. Heart Lung. 2002;31:43–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Sivitanidis E, Tosson R, Wiebalck A, et al. Combination of extracorporeal membrane oxygenation (ECMO) and pulmonary lavage in a patient with pulmonary alveolar proteinosis. Eur J Cardiothorac Surg. 1999;15:370–2.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Respiratory, Critical Care and Occupational Pulmonary MedicineUniversity of Utah Health Sciences CenterSalt Lake CityUSA

Personalised recommendations